Literature DB >> 1675359

Prevention of relapse in nasal polyposis.

G Patriarca, D Schiavino, E Nucera, G Papa, G Schinco, G Fais.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1675359     DOI： 10.1016/0140-6736(91)93185-c

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?

Authors:  Ludger Klimek; Ralph Dollner; Oliver Pfaar; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

2.  Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies.

Authors:  E Nucera; D Schiavino; A Milani; M Del Ninno; C Misuraca; A Buonomo; C D'Ambrosio; G Paludetti; G Patriarca
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 3.  Aspirin-sensitive asthma and upper airway diseases.

Authors:  Jinny E Chang; William Chin; Ronald Simon
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

4.  Immunomodulatory treatments for aspirin exacerbated respiratory disease.

Authors:  Rachel G Moebus; Joseph K Han
Journal:  Am J Rhinol Allergy       Date:  2012 Mar-Apr       Impact factor: 2.467

5.  A retrospective study on long-term efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease.

Authors:  Alfonso Luca Pendolino; Glenis K Scadding; Bruno Scarpa; Peter J Andrews
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-09-04       Impact factor: 3.236
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.